Back to Biology

BERG is a clinical-stage, AI-powered biotechnology company taking a bold ‘Back to Biology™’ approach to healthcare. By leveraging our proprietary intelligence platform – Interrogative Biology®, our goal is to map disease and revolutionize treatments for patients around the world.

Our Vision

By harnessing the power of AI, coupled with patient biology, we aim to accelerate clinical identification and pursuit of promising therapeutic targets to treat disease. This means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems. By going ‘Back to Biology’, we believe we can drive healthcare forward.

Our Focus



Rare Disease

Progress, for People

At BERG, we believe in making Progress, for People. People not only inspire the work we do, but are at the center of our R&D. BERG harnesses the true potential of modern technology to gather trillions of data points to map diseases in unprecedented detail. This revolutionary approach aims to bring new treatments and new hope to the millions of patients and caregivers in need of novel treatment options.

BERG in the news

BERG in the News!

BERG is making headlines.  Click here to see the latest breaking news, interviews, and press releases.